Fully automated optofluidic manipulation of single cells for advancing the global healthcare industry towards personalized medicine
Falko Schmidt
Online, 23 September 2020
12:15 PM
Abstract:
Covid-19 has shown us that individuals are affected very differently by the disease. Now more than ever the healthcare industry is transitioning towards personalized medicine. In this talk we will show how cutting-edge technology can be used to understand how such complex diseases differ at the single-cell level. We combine three core technologies, artificial intelligence, microfluidics and optical manipulation to create an automated and user-friendly tool for researchers across various disciplines.
Learning outcomes:
Falko Schmidt
Online, 23 September 2020
12:15 PM
Abstract:
Covid-19 has shown us that individuals are affected very differently by the disease. Now more than ever the healthcare industry is transitioning towards personalized medicine. In this talk we will show how cutting-edge technology can be used to understand how such complex diseases differ at the single-cell level. We combine three core technologies, artificial intelligence, microfluidics and optical manipulation to create an automated and user-friendly tool for researchers across various disciplines.
Learning outcomes:
- Get to know why biologists and pharmaceuticals currently struggle with population studies and how single-cell studies could be the key
- Gain basic understanding of contactless and non-invasive methods for single cell manipulation
- Learn about how AI algorithms can automatically recognized and classify different cell types
- Gain insights into how three different technologies; photonics, microfluidics and AI can be seamlessly integrated into a single fully automated platform
